Quincy Bioscience Supporting Prevagen Study

MADISON, Wis.Quincy Bioscience is sponsoring a new study, the Prevagen Memory Loss Study, examining how its Prevagen® dietary supplement impacts cognitive function and other quality of life measures in adults experiencing some memory loss. The company made the announcement in conjunction with the start of Brain Awareness Week (BAW), a global campaign founded by the Dana Alliance for Brain Initiatives designed to increase public awareness about the progress and benefits of brain research.

The new memory loss study, a randomized, placebo-controlled, double blind investigation, will evaluate the impact of Prevagen on brain cell protection, and will require five cognitive testing sessions during the three-month study period. Prevagens main ingredient is a naturally occurring calcium-binding protein, apoaequorin, discovered in jellyfish.

Mark Underwood, president, Quincy Bioscience, said, We are excited about the new Prevagen Memory Study. We are researching various areas in order to bring hope to people with different health challenges related to aging and memory with the goal of improving quality of life. Additionally, we are doing a series of educational radio shows during March Brain Awareness Week to help raise brain awareness.